Krsnaa Diagnostics IPO GMP, Subscription Status, Share Price, Dates, Review

Krsnaa Diagnostics IPO becomes the 4th entry to launch on 4th August. Get to know Krsnaa IPO grey market premium, Subscription Status, Share Price, Dates, Review, and more

by FighterMan Updated: 16 Aug, 2021, 11:09 IST
2 3054

Krsnaa Diagnostics IPO will clash with Windlas Biotech, Devyani International, and Exxaro Tiles in August 2021. This Pune based company is into Radiology, Pathology, Teleradiology, and other diagnosis services. Its fresh issue is of Rs 400 crores. We will go through the Krsnaa Diagnostics IPO GMP (grey market premium), Subscription Status, Share Price, Dates, Review, and more so that you get a fair idea about whether to invest in this IPO or go for the other 3. 

krsnaa diagnostics ipo
Krsnaa Diagnostics Limited Company Profile

Krsnaa Diagnostics Limited is India’s largest Radiology (x-ray, MRI) and Pathology diagnostic services provider. It got started in 2011. This company is present in 14 states and 1800+ areas of India. Moreover, it claims to have served 13M+ patients. Besides, it has done 7,50,000+ Covid-19 PCR tests.

It has given services in private & public hospitals, medical colleges, and community health centres. It had 1801 diagnostic centres across 13 cities in India as of 2020. In addition, the company has PPP contracts with NHM funded central government agencies, state healthcare agencies, municipal corporations and Indian Railways hospitals.

Krsnaa Diagnostics IPO Details

Check Krsnaa Diagnostics IPO Details on its public issue and available subscription quotas.

Krsnaa Diagnostics IPO Issue Size

Rs 1213 crores

Fresh Issue

Rs 400 crores

Krsnaa Diagnostics IPO Offer-for-sale

85,25,520 shares

Krsnaa Diagnostics IPO Face Value

Rs 5 per equity share

QIB quota

75%

NII quota

15%

Krsnaa Diagnostics IPO Retail quota

10%

Krsnaa Diagnostics IPO Dates

Get to know all the Krsnaa Diagnostics IPO Dates.

Krsnaa Diagnostics IPO Opening Date

4th August

Krsnaa Diagnostics IPO Closing Date

6th August

Refunds

12th August

Krsnaa Diagnostics IPO Allotment Date

11th August

Shares Credit Date

13th August

Krsnaa Diagnostics IPO Listing Date on NSE and BSE

17th August

Krsnaa Diagnostics IPO Share Price

The Krsnaa Diagnostics IPO Share Price is fixed at Rs 933-954 per equity share. 

Krsnaa Diagnostics IPO GMP aka Grey Market Premium

The Krsnaa Diagnostics IPO GMP aka Grey Market Premium is Rs 450 as of 4th August 2021, 14:14. Thus, its GMP is very good for listing gains. Moreover, its GMP increased by Rs 40 from 2nd August. The Krsnaa Diagnostics IPO GMP today (5th August 2021, 10:50) is Rs 365-380 per equity share.

Related Articles:

Exxaro Tiles IPO GMP Today, Share Price, Dates, Financials, Review

Devyani International IPO GMP Today, Dates, Share Price, Review, and more (Pizza Hut, KFC, Costa Coffee)

Windlas Biotech IPO GMP Today, Share Price, Dates, Review, and more

Nuvoco Vistas IPO GMP, Share Price, Dates, Review, and more (Nirma Group)

Krsnaa Diagnostics IPO Subscription Status

The Krsnaa Diagnostics IPO Subscription Status on day 1 is 1.79 times subscribed. Thus, 1.26 crore shares were applied for while only 71.12 lakh shares can be alloted.

Overall Retail NII QIB Employees
Day 1 1.79 times 8.53 times 12% 48% 9%
Day 2 TBA TBA TBA TBA

TBA

Day 3 TBA TBA TBA TBA TBA
Krsnaa Diagnostics IPO Kostak & Subject-to-Sauda Rates

Stay tuned for the Krsnaa Diagnostics IPO Kostak & Subject-to-Sauda Rates in this space.

Krsnaa Diagnostics IPO Lot Size

The Krsnaa Diagnostics IPO Lot Size is 15 shares with a min investment of Rs 14,310. It's max lot size is 13 lots with 195 shares and amount of Rs 1,86,030.

Krsnaa Diagnostics IPO Review : Subscribe or Not

Krsnaa Diagnostics, from the past years, increased its assets value. Moreover, its revenue grew from 214 crores to a mammoth 661 crores. Additionally, its profits rose from 58 crores to 184 crores. Therefore, its financial performance is pretty strong.

Pros:

  • India’s largest Radiology and Pathology diagnostic services provider.
  • Does 5 lakh+ tests per month in India.
  • Strong Financial record.
  • Will develop new diagnostics centres at Punjab, Karnataka, Himachal Pradesh, and Maharashtra.

Cons:

  • Still a new company in industry context so lacks a bit of experience.
  • Will be among strong peers in Metropolis and Dr Lal PathLabs
  • Need Rs 150.81 crores for new projects

Given its strong financial record, company partnership, work ethics, market position, strong GMP, and future projects, you can subscribe to Krsnaa IPO for listing and long-term gains. Before leaving check out the Latest IPO News for all the updates. 

Disclaimer : We are not SEBI registered. The information provided herein is for education purposes only. We will not be responsible for any of your profit/loss with this channel's suggestion. Consult your financial advisor before making any decision.

2 Comments  |  
3 Dimers
  • Sort By
replyuser